PharmaShots | Incisive News in 3 Shots

Subscribe Now

US

Biomarin Reports the US FDA's Acceptance of Vosoritide's NDA to Treat Children with Achondroplasia

Biomarin Reports the US FDA's Acceptance of Vosoritide's NDA to Treat Children with Achondroplasia

November 4, 2020

ViiV Healthcare's Rukobia (fostemsavir) Receives the US FDA's Approval for HIV in Patients with Limited Treatment Options

ViiV Healthcare's Rukobia (fostemsavir) Receives the US FDA's Approval for HIV in Patients with Limited Treatment Options

July 3, 2020

Zogenix's Fintepla (fenfluramine) Receives the US FDA's Approval for the Treatment of Seizures Associated with Dravet Syndrome

Zogenix's Fintepla (fenfluramine) Receives the US FDA's Approval for the Treatment of Seizures Associated with Dravet Syndrome

June 26, 2020

AbbVie to Divest Allergan's Brazikumab and Zenpep (pancrelipase) to Gain the US FTC and EC's Approval on Pending Allergan Acquisition

AbbVie to Divest Allergan's Brazikumab and Zenpep (pancrelipase) to Gain the US FTC and EC's Approval on Pending Allergan Acquisit...

January 27, 2020

Sandoz's Ziextenzo (biosimilar- pegfilgrastim) Receives the US FDA's Approval to Decrease the Incidence of Febrile Neutropenia

Sandoz's Ziextenzo (biosimilar- pegfilgrastim) Receives the US FDA's Approval to Decrease the Incidence of Febrile Neutropenia

November 5, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us